336 related articles for article (PubMed ID: 34242264)
1. Comparisons of plasma aldosterone and renin data between an automated chemiluminescent immunoanalyzer and conventional radioimmunoassays in the screening and diagnosis of primary aldosteronism.
Tamura N; Watanabe E; Shirakawa R; Nakatani E; Yamada K; Hatakeyama H; Torii-Hanakita M; Kyo C; Kosugi R; Ogawa T; Kotani M; Usui T; Inoue T
PLoS One; 2021; 16(7):e0253807. PubMed ID: 34242264
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of primary aldosteronism: comparison of post-captopril active renin concentration and plasma renin activity.
Wu VC; Kuo CC; Chang HW; Tsai CT; Lin CY; Lin LY; Lin YH; Wang SM; Huang KH; Fang CC; Ho YL; Liu KL; Chang CC; Chueh SC; Lin SL; Yen RF; Wu KD;
Clin Chim Acta; 2010 May; 411(9-10):657-63. PubMed ID: 20117105
[TBL] [Abstract][Full Text] [Related]
3. Aldosterone LC-MS/MS Assay-Specific Threshold Values in Screening and Confirmatory Testing for Primary Aldosteronism.
Guo Z; Poglitsch M; McWhinney BC; Ungerer JPJ; Ahmed AH; Gordon RD; Wolley M; Stowasser M
J Clin Endocrinol Metab; 2018 Nov; 103(11):3965-3973. PubMed ID: 30137438
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of the ratio of plasma aldosterone to rennin concentration measured by an automated chemiluminescent immunoassay in screening for primary aldosteronism].
Song Y; He W; Yang S; Cheng Q; Hu J; Zhen Q; Long J; Feng Z; Li R; Wang Z; Ren W; Zhou B; Li Q
Zhonghua Nei Ke Za Zhi; 2016 Jan; 55(1):6-10. PubMed ID: 26796645
[TBL] [Abstract][Full Text] [Related]
5. Screening for primary aldosteronism in an argentinian population: a multicenter prospective study.
Leal Reyna M; Gómez RM; Lupi SN; Belli SH; Fenili CA; Martínez MS; Ruibal GF; Rossi MA; Chervin RA; Cornaló D; Contreras LN; Costa L; Nofal MT; Damilano SA; Pardes EM
Arch Endocrinol Metab; 2015 Oct; 59(5):441-7. PubMed ID: 26222233
[TBL] [Abstract][Full Text] [Related]
6. Clinical validation for the aldosterone-to-renin ratio and aldosterone suppression testing using simultaneous fully automated chemiluminescence immunoassays.
Manolopoulou J; Fischer E; Dietz A; Diederich S; Holmes D; Junnila R; Grimminger P; Reincke M; Morganti A; Bidlingmaier M
J Hypertens; 2015 Dec; 33(12):2500-11. PubMed ID: 26372319
[TBL] [Abstract][Full Text] [Related]
7. Adrenal venous sampling criteria for chemiluminescent enzyme immunoassay as a preferable alternative to radioimmunoassay in primary aldosteronism.
Nakai K; Tsurutani Y; Irie K; Teruyama K; Suematsu S; Matsui S; Makita K; Saito J; Omura M; Nishikawa T
Endocr J; 2024 May; 71(5):461-469. PubMed ID: 38417879
[TBL] [Abstract][Full Text] [Related]
8. Predictors of confirmatory test results for the diagnosis of primary hyperaldosteronism in hypertensive patients with an aldosterone-to-renin ratio greater than 20. The SHRIMP study.
Okamoto R; Taniguchi M; Onishi Y; Kumagai N; Uraki J; Fujimoto N; Fujii E; Yano Y; Ogura T; Ito M
Hypertens Res; 2019 Jan; 42(1):40-51. PubMed ID: 30401909
[TBL] [Abstract][Full Text] [Related]
9. Primary aldosteronism: Aldosterone/renin ratio cut-off points.
Eugenio Russmann ML; Delfino L; Fierro F; Santoro S; Peréz M; Caruso G; Glikman P; Gauna A; Lupi S
Endocrinol Diabetes Nutr (Engl Ed); 2019; 66(6):361-367. PubMed ID: 30737120
[TBL] [Abstract][Full Text] [Related]
10. Novel chemiluminescent immunoassay to measure plasma aldosterone and plasma active renin concentrations for the diagnosis of primary aldosteronism.
Teruyama K; Naruse M; Tsuiki M; Kobayashi H
J Hum Hypertens; 2022 Jan; 36(1):77-85. PubMed ID: 33564064
[TBL] [Abstract][Full Text] [Related]
11. Criteria for diagnosing primary aldosteronism on the basis of liquid chromatography-tandem mass spectrometry determinations of plasma aldosterone concentration.
Baron S; Amar L; Faucon AL; Blanchard A; Baffalie L; Faucard C; Travers S; Pagny JY; Azizi M; Houillier P
J Hypertens; 2018 Jul; 36(7):1592-1601. PubMed ID: 29677048
[TBL] [Abstract][Full Text] [Related]
12. The captopril challenge test for diagnosing primary Aldosteronism in a Chinese population.
Zhu KY; Zhang Y; Zhang WJ; Li HY; Feng WH; Zhu DL; Li P
BMC Endocr Disord; 2019 Jun; 19(1):65. PubMed ID: 31234846
[TBL] [Abstract][Full Text] [Related]
13. Construction of a predictive scoring system as a guide to screening and confirmation of the diagnosis of primary aldosteronism.
Kietsiriroje N; Wonghirundecha R; Suntornlohanakul O; Murray RD
Clin Endocrinol (Oxf); 2020 Mar; 92(3):196-205. PubMed ID: 31840266
[TBL] [Abstract][Full Text] [Related]
14. Analytical validation and investigation on reference intervals of aldosterone and renin in Chinese Han population by using fully automated chemiluminescence immunoassays.
Deng L; Xiong Z; Li H; Lei X; Cheng L
Clin Biochem; 2018 Jun; 56():89-94. PubMed ID: 29684370
[TBL] [Abstract][Full Text] [Related]
15. [The application of captopril challenge test in the diagnosis of primary aldosteronism].
Chen S; Zeng ZP; Song AL; Zhu L; Lu L; Tong AL; Shi C; Li HZ
Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):402-408. PubMed ID: 28592038
[No Abstract] [Full Text] [Related]
16. Diagnostic accuracy of aldosterone and renin measurement by chemiluminescent immunoassay and radioimmunoassay in primary aldosteronism.
Burrello J; Monticone S; Buffolo F; Lucchiari M; Tetti M; Rabbia F; Mengozzi G; Williams TA; Veglio F; Mulatero P
J Hypertens; 2016 May; 34(5):920-7. PubMed ID: 27031933
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of characteristics of renin, aldosterone and aldosterone/renin ratio in patients with aldosterone-producing adenoma].
He YB; Yu X; Zhou XR; Shu BH; Liu JH
Zhonghua Yi Xue Za Zhi; 2013 Nov; 93(42):3379-83. PubMed ID: 24418036
[TBL] [Abstract][Full Text] [Related]
18. [Screening tests and diagnostic examinations of hypertensives for primary aldosteronism].
Omura M; Nishikawa T
Rinsho Byori; 2006 Nov; 54(11):1157-63. PubMed ID: 17240838
[TBL] [Abstract][Full Text] [Related]
19. Comparison of active renin concentration and plasma renin activity for the diagnosis of primary hyperaldosteronism in patients with an adrenal mass.
Unger N; Lopez Schmidt I; Pitt C; Walz MK; Philipp T; Mann K; Petersenn S
Eur J Endocrinol; 2004 Apr; 150(4):517-23. PubMed ID: 15080782
[TBL] [Abstract][Full Text] [Related]
20. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML
Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
